Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1702316

registered interest
date	18/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Magnetic Resonance Imagers: Helium
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking to ensure minimal usage of helium in MRI scanners in NHS facilities in the light of the global shortage of helium; and what steps they are taking to ensure all helium in scanners being replaced is reused appropriately.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL3927
answer	answer is ministerial correction date of answer 25/04/2024 answer text <p>Suppliers of magnetic resonance imaging (MRI) scanners are moving to a sealed helium solution, whereby the helium required to cool the magnet is approximately 0.5% of the current levels. These sealed systems will also ensure MRI scanners do not require further helium to be added during years of operational use.</p><p>Furthermore, suppliers are now replacing MRI scanners without requiring the magnet to be replaced, though this is only available for the first replacement cycle, whereby the scanner is fully replaced, but the existing magnet and helium are retained.</p><p>With regards to the Department, as set out in the recent Medical Technology Strategy: One Year On publication, the Design for Life Programme has been stood up to work with industry, the health and care sector, and academic partners to develop medical technology systems that support reuse, remanufacture, and material recovery becoming the default. This includes developing regulatory, commercial, digital, and policy environments that support this aim. The Department’s intention is to publish a roadmap later this year to articulate our relevant findings and plans moving forward.</p> answering member printed Lord Markham question first answered 25/04/2024 14:24:02 answering member 4948 label Biography information for Lord Markham
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1702353

registered interest
date	18/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services and Social Services
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what progress they have made on integrating social care and the NHS.
tabling member printed	Lord Swire
uin	HL3964
answer	answer is ministerial correction date of answer 25/04/2024 answer text <p>The Health and Care Act 2022 established integrated care systems, reforming how health and adult social care work together by putting partnership at the heart of planning. The Government has published guidance for integrated care partnerships (ICPs), on the statutory requirement for each ICP to publish an Integrated Care Strategy to address the health, social care, and public health needs of their system. All ICPs have now published their integrated care strategies.</p><p>The integration of health and social care is often best achieved through collaboration across smaller geographies within integrated care systems called places. Since the Health and Care Act 2022, we have seen good progress in the development of place-based arrangements to integrate health and social care. In October 2023, we published our Shared Outcomes Toolkit designed to help place-based partnerships develop shared outcomes as a powerful means of promoting integrated working and joined up care. We also issued a call for evidence as part of our review of Section 75 of the NHS Act 2006, which permits local authorities and National Health Service bodies to pool budgets, enabling joint commissioning and the commissioning of integrated services. The findings of this review will be shared in due course.</p> answering member printed Lord Markham question first answered 25/04/2024 14:16:30 answering member 4948 label Biography information for Lord Markham
tabling member	1408 label Biography information for Lord Swire

1701967

registered interest
date	17/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Waiting Lists
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government when they expect updated NHS wait times to be published for 2022 and 2023.
tabling member printed	Baroness Goudie
uin	HL3882
answer	answer is ministerial correction date of answer 23/04/2024 answer text <p>NHS England publishes Referral to Treatment Waiting Times data for elective treatment monthly in an online-only format, including for 2022 and 2023. There are no plans to revise waiting times figures for these years.</p> answering member printed Lord Markham question first answered 23/04/2024 11:39:06 answering member 4948 label Biography information for Lord Markham
tabling member	3575 label Biography information for Baroness Goudie

1701968

registered interest
date	17/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Diagnosis
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking to ensure that the NHS is prepared for the arrival of new diagnostic innovations for dementia.
tabling member printed	Baroness Goudie
uin	HL3883
answer	answer is ministerial correction date of answer 25/04/2024 answer text <p>The National Health Service is a world leader in rolling out innovative treatments and has established a dedicated national programme team which is working in partnership with other national agencies and with local health systems to prepare for the potential roll out of new treatments for use in the earlier stages of Alzheimer’s disease. These plans assume that, if these new treatments are approved by the regulators, significant additional diagnostic capacity, including amyloid positron emission tomography–computed tomography, lumbar puncture and magnetic resonance imaging, will be needed both to identify patients who are most able to benefit and to provide important safety monitoring.</p><p>The national programme team is conducting preparations across the country, working alongside clinicians and local teams to identify where further funding will be required to roll out the additional tests and services needed to introduce these new and complex treatments.</p><p>NHS England is also working with partner agencies to support and inform further research into other diagnostic modalities, including blood-based biomarker and digital tests, which will help improve identification and management of Alzheimer’s disease.</p> answering member printed Lord Markham question first answered 25/04/2024 14:26:03 answering member 4948 label Biography information for Lord Markham
tabling member	3575 label Biography information for Baroness Goudie

1701979

registered interest
date	17/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Staff
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the potential impact on the mental health and wellbeing of secondary care staff if their partnership with NHS Practitioner Health is ended after the 12-month review period.
tabling member printed	Baroness Merron
uin	HL3894
answer	answer is ministerial correction date of answer 23/04/2024 answer text <p>We recognise that the NHS Practitioner Health service is valued by many doctors. NHS England is reviewing the service as part of a wider review of its mental health and wellbeing offer to National Health Service staff. It was confirmed on 15 April 2024 that the service will continue to accept new patients from primary and secondary care whilst this review is undertaken over the next 12 months. NHS England will assess the impact and confirm future arrangements once the review has been completed.</p> answering member printed Lord Markham question first answered 23/04/2024 16:06:17 answering member 4948 label Biography information for Lord Markham
tabling member	347 label Biography information for Baroness Merron

1701981

registered interest
date	17/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Insurance: Private Sector
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what regulations are in place to ensure that the care and treatment provided by private medical insurers are the most appropriate for a specific patient.
tabling member printed	Baroness Merron
uin	HL3896
answer	answer is ministerial correction date of answer 23/04/2024 answer text <p>Private medical insurers purchase services from independent sector providers who are responsible for delivering healthcare.</p><p>All providers of healthcare are regulated by the Care Quality Commission and follow a set of fundamental standards of safety and quality below which care should never fall, while the General Medical Council is responsible for regulating doctors in the United Kingdom.</p> answering member printed Lord Markham question first answered 23/04/2024 16:04:59 answering member 4948 label Biography information for Lord Markham
tabling member	347 label Biography information for Baroness Merron

1701999

registered interest
date	17/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Market Sustainability and Improvement Fund
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what progress they have made in allocating the Market Sustainability and Improvement Fund 2023 to 2024 for adult social care; and what are their plans for allocation in the financial year 2024–25.
tabling member printed	The Lord Bishop of Southwark
uin	HL3914
answer	answer is ministerial correction date of answer 24/04/2024 answer text <p>The Market Sustainability and Improvement Fund (MSIF) gives an overall profile of almost £2 billion over two years. Local authorities can choose to use the funding to increase fee rates paid to adult social care providers, increase adult social care workforce capacity and retention, and reduce adult social care waiting times.</p><p>In 2023/34, a total of £927 million was made available to local authorities via MSIF, with a further £1.05 billion being made available in 2024/25. The funding has been distributed using the adult social care relative needs formula. Full local authority allocations for 2024/25 are available in the Market Sustainability and Improvement Fund Grant Determination 2024 to 2025 on GOV.UK in an online-only format.</p> answering member printed Lord Markham question first answered 24/04/2024 11:45:14 answering member 4948 label Biography information for Lord Markham
tabling member	4345 label Biography information for The Lord Bishop of Southwark

1701608

registered interest
date	16/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Integrated Care Boards: Finance
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what was the financial position of each integrated care board at the end of financial year 2023–24.
tabling member printed	Lord Bradley
uin	HL3839
answer	answer is ministerial correction date of answer 23/04/2024 answer text <p>The financial year-end reports for integrated care boards are still in progress and not yet finalised. We anticipate that final, audited reports will be completed and available in July 2024.</p> answering member printed Lord Markham question first answered 23/04/2024 16:23:48 answering member 4948 label Biography information for Lord Markham
tabling member	452 label Biography information for Lord Bradley

1701610

registered interest
date	16/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Prices
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what progress they have made with the proposed amendments to the Part IX of the Drug Tariff, including any impact assessments on the future provision of medical technologies in the UK; how these proposals meet the ambitions of the Life Sciences Vision; and what steps they are taking to ensure that there is sufficient patient choice following the outcome of the consultation.
tabling member printed	Baroness Finlay of Llandaff
uin	HL3841
answer	answer is ministerial correction date of answer 22/04/2024 answer text <p>The consultation response on the proposed amendments to Part IX and the final impact assessment is expected to be released in May 2024, and will outline the Government’s response.</p><p>The Department believes that it is currently difficult to identify which devices are broadly comparable, and whether more expensive devices provide added value. The proposed amendments that were consulted on intend to increase meaningful choice, not to decrease choice for clinicians and patients. Comparison between products can increase awareness of different brands amongst prescribers.</p><p>These proposals support the Life Sciences Vision, and are designed to increase innovation and alignment between partners in the health and care system. The enhanced assessment process will allow comparison between products based on their merits, increasing transparency and competition, and encouraging new products and small and medium sized businesses to enter the market. The proposed introduction of environmental attributes in social value scoring increases the vision to help the National Health Service meet Net Zero.</p><p>The Department is aware that there are some very good devices in use, relied upon by clinicians and patients. Part IX will remain a list of devices available to be prescribed in the community via the FP10 prescription route. Any amendments that are taken forward will happen gradually, with review points and engagement with stakeholders, including industry, patient representatives, clinicians, and NHS organisations. The Department will share a timeline of proposed changes taken forward, in due course.</p> answering member printed Lord Markham grouped question UIN HL3842 question first answered 22/04/2024 15:04:52 answering member 4948 label Biography information for Lord Markham
tabling member	3609 label Biography information for Baroness Finlay of Llandaff

1701611

registered interest
date	16/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Prices
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government how they plan to formally engage with the wider health sector and industry partners on the next stages in the development of proposed changes to Part IX of the Drug Tariff, following the conclusion of the consultation on these proposals.
tabling member printed	Baroness Finlay of Llandaff
uin	HL3842
answer	answer is ministerial correction date of answer 22/04/2024 answer text <p>The consultation response on the proposed amendments to Part IX and the final impact assessment is expected to be released in May 2024, and will outline the Government’s response.</p><p>The Department believes that it is currently difficult to identify which devices are broadly comparable, and whether more expensive devices provide added value. The proposed amendments that were consulted on intend to increase meaningful choice, not to decrease choice for clinicians and patients. Comparison between products can increase awareness of different brands amongst prescribers.</p><p>These proposals support the Life Sciences Vision, and are designed to increase innovation and alignment between partners in the health and care system. The enhanced assessment process will allow comparison between products based on their merits, increasing transparency and competition, and encouraging new products and small and medium sized businesses to enter the market. The proposed introduction of environmental attributes in social value scoring increases the vision to help the National Health Service meet Net Zero.</p><p>The Department is aware that there are some very good devices in use, relied upon by clinicians and patients. Part IX will remain a list of devices available to be prescribed in the community via the FP10 prescription route. Any amendments that are taken forward will happen gradually, with review points and engagement with stakeholders, including industry, patient representatives, clinicians, and NHS organisations. The Department will share a timeline of proposed changes taken forward, in due course.</p> answering member printed Lord Markham grouped question UIN HL3841 question first answered 22/04/2024 15:04:52 answering member 4948 label Biography information for Lord Markham
tabling member	3609 label Biography information for Baroness Finlay of Llandaff